The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting

BMC Public Health

Graeme P Maguire⁴  Sue Metcalf³  Dennis Gray²  Carmel Nelson³  Tracey Kitaura¹  David Atkinson³  Julia V Marley³ 

[1] Derby Aboriginal Health Service, 1 Stanley Street, PO Box 1155, Derby, WA 6728, Australia;National Drug Institute, Curtin University, GPO Box U1987, Perth, WA 6845, Australia;Kimberley Aboriginal Medical Services Council, 12 Napier Terrace, PO Box 1377, Broome, WA 6725, Australia;Baker IDI, Alice Springs, Northern Territory 0871, Australia

关键词: Be Our Ally Beat Smoking (BOABS) Study;    Smoking cessation;    Randomised controlled trial;    Torres Strait Islander;    Aboriginal;    Indigenous;   

Others  :  1161351
DOI  :  10.1186/1471-2458-14-32

 received in 2013-07-09, accepted in 2013-12-20,  发布年份 2014

【 摘 要 】

Background

Australian Aboriginal and Torres Strait Islander peoples (Indigenous Australians) smoke at much higher rates than non-Indigenous people and smoking is an important contributor to increased disease, hospital admissions and deaths in Indigenous Australian populations. Smoking cessation programs in Australia have not had the same impact on Indigenous smokers as on non-Indigenous smokers. This paper describes the outcome of a study that aimed to test the efficacy of a locally-tailored, intensive, multidimensional smoking cessation program.

Methods

A randomised controlled trial of Aboriginal researcher delivered tailored smoking cessation counselling during face-to-face visits, aiming for weekly for the first four weeks, monthly to six months and two monthly to 12 months. The control (“usual care”) group received routine care relating to smoking cessation at their local primary health care service. Data collection occurred at enrolment, six and 12 months. The primary outcome was self-reported smoking cessation with urinary cotinine confirmation at final follow-up (median 13 (interquartile range 12–15) months after enrolment).

Results

Participants in the intervention (n = 55) and usual care (n = 108) groups were similar in baseline characteristics, except the intervention group was slightly older. At final follow-up the smoking cessation rate for participants assigned to the intervention group (n = 6; 11%), while not statistically significant, was double that of usual care (n = 5; 5%; p = 0.131). A meta-analysis of these findings and a similarly underpowered but comparable study of pregnant Indigenous Australian women showed that Indigenous Australian participants assigned to the intervention groups were 2.4 times (95% CI, 1.01-5.5) as likely to quit as participants assigned to usual care.

Conclusions

Culturally appropriate, multi-dimensional Indigenous quit smoking programs can be successfully implemented in remote primary health care. Intensive one-on-one interventions with substantial involvement from Aboriginal and Torres Strait Islander workers are likely to be effective in these settings.

Trial registration

Australian New Zealand Clinical Trials Registry (ACTRN12608000604303).

【 授权许可】

   
2014 Marley et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Thomas DP: Changes in smoking intensity among Aboriginal and Torres Strait Islander people, 1994–2008. Med J Aust 2012, 197(9):503-506.
• [2]Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol 2009, 38(2):470-477.
• [3]Trewin D, Madden R: The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples. Canberra: Australian Bureau of Statistics & Australian Institute of Health and Welfare; 2005.
• [4]American Diabetes Association: Standards of medical care in diabetes--2006. Diabetes Care 2006, 29(1):S4-S42.
• [5]Lemmens V, Oenema A, Knut IK, Brug J: Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008, 17(6):535-544.
• [6]Carson KV, Brinn MP, Peters M, Veale A, Esterman AJ, Smith BJ: Interventions for smoking cessation in Indigenous populations. Cochrane Database Syst Rev 2012., 1CD009046
• [7]Bryant J, Bonevski B, Paul C, McElduff P, Attia J: A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 2011, 106(9):1568-1585.
• [8]Eades SJ, Sanson-Fisher RW, Wenitong M, Panaretto K, D’Este C, Gilligan C, Stewart J: An intensive smoking intervention for pregnant Aboriginal and Torres Strait Islander women: a randomised controlled trial. Med J Aust 2012, 197(1):42-46.
• [9]Ivers RG: An evidence-based approach to planning tobacco interventions for Aboriginal people. Drug Alcohol Rev 2004, 23(1):5-9.
• [10]Marley JV, Dent HK, Wearne M, Fitzclarence C, Nelson C, Siu K, Warr K, Atkinson D: Haemodialysis outcomes of Aboriginal and Torres Strait Islander patients of remote Kimberley region origin. Med J Aust 2010, 193(9):516-520.
• [11]Marley JV, Nelson C, O’Donnell V, Atkinson D: Quality indicators of diabetes care: an example of remote-area Aboriginal primary health care over 10 years. Med J Aust 2012, 197(7):404-408.
• [12]Panaretto KS, Lee HM, Mitchell MR, Larkins SL, Manessis V, Buettner PG, Watson D: Impact of a collaborative shared antenatal care program for urban Indigenous women: a prospective cohort study. Med J Aust 2005, 182(10):514-519.
• [13]Marley JV, Atkinson D, Nelson C, Kitaura T, Gray D, Metcalf S, Murray R, Maguire GP: The protocol for the Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote Aboriginal Australian health care setting. BMC public health 2012, 12(1):232. BioMed Central Full Text
• [14]McDonald SP, Maguire GP, Hoy WE: Validation of self-reported cigarette smoking in a remote Australian Aboriginal community. Aust N Z J Public Health 2003, 27(1):57-60.
• [15]Tuomi T, Johnsson T, Reijula K: Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. Clinical chemistry 1999, 45(12):2164-2172.
• [16]Linacre S: National Aboriginal and Torres Strait Islander Social Survey 2002. In. Australian Bureau of Statistics: Canberra; 2004.
• [17]Schulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
• [18]Ivers RG, Farrington M, Burns CB, Bailie RS, D’Abbs PH, Richmond RL, Tipiloura E: A study of the use of free nicotine patches by Indigenous people. Aust N Z J Public Health 2003, 27(5):486-490.
• [19]Johnson KM, Lando HA, Schmid LS, Solberg LI: The GAINS project: outcome of smoking cessation strategies in four urban Native American clinics. Giving American Indians No-smoking Strategies. Addictive behaviors 1997, 22(2):207-218.
• [20]Holt S, Timu-Parata C, Ryder-Lewis S, Weatherall M, Beasley R: Efficacy of bupropion in the indigenous Maori population in New Zealand. Thorax 2005, 60(2):120-123.
• [21]Bramley D, Riddell T, Whittaker R, Corbett T, Lin RB, Wills M, Jones M, Rodgers A: Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori. The New Zealand medical journal 2005, 118(1216):U1494.
• [22]Velicer WF, Prochaska JO: A comparison of four self-report smoking cessation outcome measures. Addictive behaviors 2004, 29(1):51-60.
• [23]Therapeutic Goods Administration: Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95 - Annotaed with TGA comments). Canberra: Commonwealth Department of Health and Aged Care; 2000.
• [24]National Health and Medical Research Council, Australian Research Council, Australian Vice-Chancellors’ Committee: The National Statement on Ethical Conduct in Human Research. Canberra: Australian Government; 2007.
• [25]National Health and Medical Research Council: Values and Ethics - Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Health Research. Canberra: Commonwealth of Australia; 2003.
• [26]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86(9):1119-1127.
• [27]Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T: Physician advice for smoking cessation. Cochrane Database Syst Rev 2013., 5CD000165
• [28]Couzos S, Lea T, Mueller R, Murray R, Culbong M: Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Med J Aust 2003, 179(4):185-190.
• [29]Hatcher S, Sharon C, Coggan C: Beyond randomized controlled trials in attempted suicide research. Suicide & life-threatening behavior 2009, 39(4):396-407.
• [30]Victora CG, Habicht JP, Bryce J: Evidence-based public health: moving beyond randomized trials. American journal of public health 2004, 94(3):400-405.
• [31]Campbell MK, Piaggio G, Elbourne DR, Altman DG: Consort 2010 statement: extension to cluster randomised trials. BMJ 2012, 345:e5661.